References
- Fabregues F, Penarrubia J, Creus M, et al. Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial. Hum Reprod 2009;24:349–59.
- Venetis CA, Kolibianakis EM, Talatzi TB, et al. Evidence-based management of poor ovarian response. Ann NY Acad Sci 2010;1205:199–206.
- Lan VTN. Đáp úng kém với kích thích buồng trúng [Low response with ovarian stimulation]. Reprod Health Mag 2003;5:8–9.
- Balasch J, Francisco F. Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor responder IVF patients with normal basal concentrations of FSH. Hum Reprod 2006;21:1884–93.
- Kim CH, Howles CM, Lee HA. The effect of transdermal testosterone gel pretreatment on controlled ovarianstimulation and IVF outcome in low responders. Fertil Steril 2011;95:679–83.
- Ono YJ, Tanabe A, Nakamura Y, et al. A Low-testosterone state associated with endometrioma leads to the apoptosis of granulosa cells. PLoS One. 2014;9:e115618.
- Nagels HE, Rishworth JR, Siristatidis CS, Kroon B. Androgens (dehydroepiandrosterone or testosterone) in women undergoing assisted reproduction. Cochrane Database Syst Rev 2012;3:CD009749.
- Nagels HE, Rishworth JR, Siristatidis CS, Kroon B. Androgens (dehydroepiandrosterone or testosterone) in women undergoing assisted reproduction. Cochrane Database Syst Rev 2015;11:CD009749.
- Humaidan P, Ejdrup Bredkjer H, Bungum L, et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod 2005;20:1213–20.
- Walters KA, et al. Role of androgens in normal and pathological ovarian function. Hum Reprod 2015;149:R193–218.